Table 1.
The relationship between AEBP1 expression and clinicopathological features in patients with gastric cancer.
Prognostic variables | Number | AEBP1 expression | χ2 | P | |
---|---|---|---|---|---|
Low | High | ||||
Sex | 0.446 | 0.504 | |||
Male | 113 | 51 | 62 | ||
Female | 53 | 21 | 32 | ||
Age (years) | 0.563 | 0.453 | |||
≥60 | 63 | 25 | 38 | ||
<60 | 103 | 47 | 56 | ||
Tumor location | 0.271 | 0.603 | |||
Proximal | 59 | 24 | 35 | ||
Distal | 107 | 48 | 59 | ||
Histological grade | 0.004 | 0.950 | |||
G1 + G2 | 48 | 21 | 27 | ||
G3 | 118 | 51 | 67 | ||
T stage | 7.986 | 0.005 | |||
T1-T2 | 65 | 37 | 28 | ||
T3-T4 | 101 | 35 | 66 | ||
N stage | 8.068 | 0.005 | |||
N0 | 76 | 42 | 34 | ||
N1-N3 | 90 | 30 | 60 | ||
M stage | 1.733 | 0.188 | |||
M0 | 157 | 70 | 87 | ||
M1 | 9 | 2 | 7 | ||
TNM stage | 8.343 | 0.004 | |||
I + II | 114 | 58 | 56 | ||
III + IV | 52 | 14 | 38 |